Back to search
FDAFDA · Food and drugs·Recall number D-0645-2025

Aripiprazole Tablets, USP, 10 mg, 30-count bottles, Rx only, Manufactured by: Alken Laboratories Ltd., INDIA; Distributed by: Ascend Laboratories, LLC, Parsippany, NJ 07054. NDC: 67877-432-03

Published September 24, 2025 · Recall initiated: August 28, 2025

Summary

FDA records drug Class II recall D-0645-2025, published September 24, 2025 and initiated August 28, 2025. Recalling firm: Ascend Laboratories, LLC; Status: Ongoing; Reported quantity: 2,256 bottles; Lot: Lot #: 24144162, Exp. Date 09/2027. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.

Status when published: Ongoing — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

Superpotent drug

What to do

Voluntary: Firm initiated · Letter

Get an email if ARIPIPRAZOLE has another recall

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Brand
ARIPIPRAZOLE
Manufacturer
Ascend Laboratories, LLC
Distributor
Nationwide in the USA.
Lot
Lot #: 24144162, Exp. Date 09/2027
Risk classification
Class II
Area (FDA)
drug
Country
United States

Related recalls

Questions about this recall

Was Aripiprazole Tablets, USP, 10 mg, 30-count bottles, Rx only, Manufactured by: Alken Laboratories Ltd., INDIA; Distributed by: Ascend Laboratories, LLC, Parsippany, NJ 07054. NDC: 67877-432-03 recalled?

Yes. FDA published recall D-0645-2025 on September 24, 2025. Reported hazard: Superpotent drug

What should I do if I have this product?

Voluntary: Firm initiated · Letter

How do I know if my unit is part of the recall?

Compare your product details with the notice. Brand: ARIPIPRAZOLE.